GDP Non-Compliance Report for Belgian Wholesale Distributor
Recommendation
9 September 2025
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
Register now for ECA's GMP Newsletter
End of October 2022, the Competent Authority of Belgium (Federal Agency for Medicines and Health Products) added a new GDP Non-Compliance Report to the EudraGMDP database.
The document dated 21 October 2022 goes back to an inspection conducted on 07 October 2022 at a wholesale distributor in Bierbeek, Belgium.
The authority blames the company in question for a whole series of GDP violations:
- "Importation of medicinal products without importation authorization
- sales of medicinal products to non-authorized societies
- holding of medicinal products in non-authorized rooms
- distribution of API without API registration
- RP does not properly perform his or her duties"
As a consequence, the wholesale distribution authorisation (WDA) was suspended.
Source: EudraGMDP Database (Inspection Date: 07 October 2022; Report Number: BE/NC/2022/03). * * To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
15.07.2025New Swissmedic Technical Interpretation on Returns of Medicinal Products
15.07.2025Two new GDP Non-Compliance Reports from Austria and Ireland published in the EudraGMDP database
15.07.2025Reminder: Participate in the GDP Implementation Survey until 31 July 2025
15.07.2025PDA Publishes Results of Transportation Validation Benchmarking Survey
10.06.2025Stimuli Article Proposes Revision of USP Definition of Controlled Room Temperature (CRT)
10.06.2025New MHRA Blog Post: Supplying Medicines to Ships, Aircraft and Oil Platforms